GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hsf4 | rn6_v1_chr19_+_37226186_37226188 | -0.29 | 2.0e-07 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_+_170475831 Show fit | 39.31 |
ENSRNOT00000006949
|
family with sequence similarity 209, member A |
|
chr17_-_44834305 Show fit | 30.10 |
ENSRNOT00000084303
|
histone cluster 1, H2bd |
|
chr9_-_14668297 Show fit | 30.01 |
ENSRNOT00000042404
|
triggering receptor expressed on myeloid cells-like 2 |
|
chr8_-_49301125 Show fit | 29.19 |
ENSRNOT00000091190
|
CD3e molecule |
|
chr11_+_86094567 Show fit | 24.46 |
ENSRNOT00000086514
|
lambda-chain C1-region-like |
|
chr14_+_3058993 Show fit | 24.13 |
ENSRNOT00000002807
|
growth factor independent 1 transcriptional repressor |
|
chr7_-_116106368 Show fit | 23.43 |
ENSRNOT00000035678
|
lymphocyte antigen 6 complex, locus K |
|
chr8_+_132828091 Show fit | 20.89 |
ENSRNOT00000008269
|
C-C motif chemokine receptor 9 |
|
chr1_-_89045586 Show fit | 20.80 |
ENSRNOT00000063808
|
zinc finger and BTB domain containing 32 |
|
chr14_-_82347679 Show fit | 20.70 |
ENSRNOT00000032972
|
transforming, acidic coiled-coil containing protein 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.4 | 32.2 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
1.7 | 30.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
4.9 | 29.2 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 29.1 | GO:0070489 | T cell activation(GO:0042110) T cell aggregation(GO:0070489) |
8.0 | 24.1 | GO:0070103 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.8 | 23.4 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
1.5 | 21.8 | GO:0030953 | astral microtubule organization(GO:0030953) |
1.2 | 20.9 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.6 | 20.5 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.7 | 19.0 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 41.3 | GO:0005882 | intermediate filament(GO:0005882) |
0.4 | 40.9 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 33.4 | GO:0005813 | centrosome(GO:0005813) |
3.6 | 29.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 21.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 19.8 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.9 | 18.9 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 18.4 | GO:0005694 | chromosome(GO:0005694) |
2.3 | 18.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
2.9 | 17.3 | GO:0071547 | piP-body(GO:0071547) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 25.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
1.4 | 20.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 20.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.4 | 20.3 | GO:0032934 | sterol binding(GO:0032934) |
5.0 | 19.8 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
1.6 | 19.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.9 | 18.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
2.3 | 18.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 18.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
2.9 | 17.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 45.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.4 | 30.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.6 | 26.0 | PID AURORA A PATHWAY | Aurora A signaling |
0.5 | 19.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 18.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.4 | 18.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 15.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.6 | 15.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 13.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 12.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.8 | 46.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
1.2 | 30.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.8 | 29.5 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
1.0 | 24.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 23.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.4 | 20.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
2.1 | 20.8 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.6 | 19.8 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
1.2 | 14.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.7 | 14.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |